Potestio L, Megna M, Villani A, Cacciapuoti S, Scalvenzi M, Martora F
Clin Cosmet Investig Dermatol. 2023; 16:3323-3331.
PMID: 38021418
PMC: 10658959.
DOI: 10.2147/CCID.S441898.
Bin Rubaian N, Aljalfan A, Almuhaidib S
J Family Community Med. 2023; 30(3):161-170.
PMID: 37675215
PMC: 10479027.
DOI: 10.4103/jfcm.jfcm_3_23.
Shafiee A, Amini M, Bahri R, Jafarabady K, Salehi S, Hajishah H
Eur J Med Res. 2023; 28(1):278.
PMID: 37559096
PMC: 10413536.
DOI: 10.1186/s40001-023-01238-9.
Cho S, Jang B, Seo J, Kim S, Lim K, Lee H
World J Clin Cases. 2023; 11(6):1419-1425.
PMID: 36926132
PMC: 10013101.
DOI: 10.12998/wjcc.v11.i6.1419.
Maple P
Vaccines (Basel). 2023; 11(2).
PMID: 36851110
PMC: 9963083.
DOI: 10.3390/vaccines11020232.
A review of neurological side effects of COVID-19 vaccination.
Hosseini R, Askari N
Eur J Med Res. 2023; 28(1):102.
PMID: 36841774
PMC: 9959958.
DOI: 10.1186/s40001-023-00992-0.
A review of the potential neurological adverse events of COVID-19 vaccines.
Mohseni Afshar Z, Sharma A, Babazadeh A, Alizadeh-Khatir A, Sio T, Taghizadeh Moghadam M
Acta Neurol Belg. 2022; 123(1):9-44.
PMID: 36385246
PMC: 9668235.
DOI: 10.1007/s13760-022-02137-2.
Cytomegalovirus Proctitis Developed after COVID-19 Vaccine: A Case Report and Literature Review.
Lv Y, Chang Y
Vaccines (Basel). 2022; 10(9).
PMID: 36146495
PMC: 9502399.
DOI: 10.3390/vaccines10091417.
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.
Martinez-Reviejo R, Tejada S, Adebanjo G, Chello C, Machado M, Parisella F
Eur J Intern Med. 2022; 104:73-79.
PMID: 35931613
PMC: 9340059.
DOI: 10.1016/j.ejim.2022.07.022.
Signaling COVID-19 Vaccine Adverse Events.
Harpaz R, DuMouchel W, Van Manen R, Nip A, Bright S, Szarfman A
Drug Saf. 2022; 45(7):765-780.
PMID: 35737293
PMC: 9219360.
DOI: 10.1007/s40264-022-01186-z.
Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
Buranasakda M, Kotruchin P, Phanthachai K, Mootsikapun P, Chetchotisakd P
Int J Infect Dis. 2022; 119:214-216.
PMID: 35367355
PMC: 8964532.
DOI: 10.1016/j.ijid.2022.03.055.
Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.
Kroumpouzos G, Paroikaki M, Yumeen S, Bhargava S, Mylonakis E
Microorganisms. 2022; 10(3).
PMID: 35336199
PMC: 8953728.
DOI: 10.3390/microorganisms10030624.
Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.
Moslemi M, Ardalan M, Haramshahi M, Mirzaei H, Khosousi Sani S, Dastgir R
BMC Infect Dis. 2022; 22(1):217.
PMID: 35241013
PMC: 8892827.
DOI: 10.1186/s12879-022-07186-9.
Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report.
Kerr C, ONeill S, Szucs A, Darmody O, Williamson C, Bannan C
IDCases. 2022; 27:e01452.
PMID: 35186672
PMC: 8837498.
DOI: 10.1016/j.idcr.2022.e01452.
Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination.
May Lee M, Macchi S, Mora E, Feliciani C
J Cosmet Dermatol. 2022; 21(4):1347-1349.
PMID: 35184368
PMC: 9115251.
DOI: 10.1111/jocd.14871.
Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.
Burlando M, Herzum A, Micalizzi C, Cozzani E, Parodi A
Immun Inflamm Dis. 2021; 10(2):265-271.
PMID: 34837354
PMC: 8767505.
DOI: 10.1002/iid3.568.
Spectrum of neurological complications following COVID-19 vaccination.
Garg R, Paliwal V
Neurol Sci. 2021; 43(1):3-40.
PMID: 34719776
PMC: 8557950.
DOI: 10.1007/s10072-021-05662-9.
Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review.
Desai H, Sharma K, Shah A, Patoliya J, Patil A, Hooshanginezhad Z
J Cosmet Dermatol. 2021; 20(11):3350-3361.
PMID: 34719084
PMC: 8597588.
DOI: 10.1111/jocd.14521.
Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports.
Katsikas Triantafyllidis K, Giannos P, Mian I, Kyrtsonis G, Kechagias K
Vaccines (Basel). 2021; 9(9).
PMID: 34579250
PMC: 8471236.
DOI: 10.3390/vaccines9091013.
A narrative review and clinical anatomy of herpes zoster infection following COVID-19 vaccination.
Iwanaga J, Fukuoka H, Fukuoka N, Yutori H, Ibaragi S, Tubbs R
Clin Anat. 2021; 35(1):45-51.
PMID: 34554601
PMC: 8652627.
DOI: 10.1002/ca.23790.
